COVID-19: Vaccines and Therapeutics

Jul 1, 2020
The Food and Drug Administration issued guidance for the development of a SARS-CoV-2 vaccine, outlining key considerations to satisfy requirements for chemistry, manufacturing and control, nonclinical and clinical data.
Jun 23, 2020
The House Energy and Commerce Committee held a hearing on the administration’s response to the COVID-19 pandemic, which featured officials from the Department of Health and Human Services, National Institute of Allergy and Infectious Diseases, Food and Drug Administration, and Centers for Disease…
Jun 10, 2020
Johnson & Johnson announced it accelerated the initiation of its first human trials of its coronavirus vaccine candidate, with the trial slated to begin in the second half of July.
May 27, 2020
Please join us this Friday, May 29, at 1 pm ET for the 6th installment of the “Securing the Health Sector” webinar series, hosted jointly by InfraGard National Capital Region (InfraGardNCR), the U.S
May 22, 2020
Criminal and nation-state cyber actors since February 2020 have been increasingly targeting US pharmaceutical, medical, and biological research facilities to acquire or manipulate sensitive information, to include COVID-19 vaccine and treatment research amid the evolving global pandemic.
May 21, 2020
A collaboration between the Department of Health and Human Services and AstraZeneca is projected to make available 300 million doses of a COVID-19 vaccine, the first of which could be available as early as October, HHS said.
May 18, 2020
The Trump administration introduced Operation Warp Speed, a $10 billion public-private partnership intended to accelerate development, manufacturing and distribution of COVID-19 vaccines, therapeutics and diagnostics by January 2021.
May 12, 2020
The federal government continues to learn lessons about distributing COVID-19 therapeutics, such as remdesivir, Food and Drug Administration Commissioner Stephen Hahn, M.D., said at a Senate Health, Education, Labor and Pensions Committee hearing.
Apr 23, 2020
The National Institutes of Health's National Institute of Allergy and Infectious Diseases released a strategic plan for accelerating research to diagnose, prevent and treat COVID-19.
Apr 17, 2020
The Department of Health and Human Services will partner with more than a dozen biopharmaceutical companies and the European Medicines Agency to prioritize vaccine and drug candidates, streamline clinical trials and coordinate regulatory processes to respond to the pandemic, the National Institutes…